{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:26:34Z","timestamp":1787167594919,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1124\/jpet.124.002254","type":"journal-article","created":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T13:10:37Z","timestamp":1728393037000},"page":"100029","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["New potential ligand-receptor axis involved in tissue repair as therapeutic targets in progressive multiple sclerosis"],"prefix":"10.1016","volume":"392","author":[{"given":"Eugenio Antonio","family":"Carrera Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4756-9889","authenticated-orcid":false,"given":"Jorge","family":"Correale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Rothlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Manuel","family":"Ortiz Wilczy\u00f1ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.124.002254_bib1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/glia.23113","article-title":"The TAM receptor Tyro3 regulates myelination in the central nervous system","volume":"65","author":"Akkermann","year":"2017","journal-title":"Glia"},{"key":"10.1124\/jpet.124.002254_bib2","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1523\/JNEUROSCI.1180-08.2008","article-title":"Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelination","volume":"28","author":"Binder","year":"2008","journal-title":"J\u00a0Neurosci"},{"key":"10.1124\/jpet.124.002254_bib3","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.immuni.2013.06.010","article-title":"T\u00a0cell-derived protein S engages TAM receptor signaling in dendritic cells to control the magnitude of the immune response","volume":"39","author":"Carrera Silva","year":"2013","journal-title":"Immunity"},{"key":"10.1124\/jpet.124.002254_bib4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.aaf1358","article-title":"The TAM family receptor tyrosine kinase TYRO3 is a negative regulator of type 2 immunity","volume":"352","author":"Chan","year":"2016","journal-title":"Science"},{"key":"10.1124\/jpet.124.002254_bib5","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.3390\/ijms24021448","article-title":"A\u00a0comprehensive exploration of the transcriptomic landscape in multiple sclerosis: a systematic review","volume":"24","author":"Chiricosta","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1124\/jpet.124.002254_bib6","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nature12776","article-title":"Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways","volume":"504","author":"Chung","year":"2013","journal-title":"Nature"},{"key":"10.1124\/jpet.124.002254_bib7","first-page":"527","article-title":"Progressive multiple sclerosis: from pathogenic mechanisms to treatment","volume":"140","author":"Correale","year":"2017","journal-title":"Brain"},{"key":"10.1124\/jpet.124.002254_bib8","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41582-022-00697-8","article-title":"The role of the gut microbiota in multiple sclerosis","volume":"18","author":"Correale","year":"2022","journal-title":"Nat Rev Neurol"},{"key":"10.1124\/jpet.124.002254_bib9","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.4049\/jimmunol.2001225","article-title":"Helminth imprinting of hematopoietic stem cells sustains anti-inflammatory trained innate immunity that attenuates autoimmune disease","volume":"206","author":"Cunningham","year":"2021","journal-title":"J\u00a0Immunol"},{"key":"10.1124\/jpet.124.002254_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.coi.2017.08.013","article-title":"Immunomodulation in multiple sclerosis: promises and pitfalls","volume":"49","author":"Dendrou","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"10.1124\/jpet.124.002254_bib11","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1124\/jpet.124.002254_bib12","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s12974-020-01982-3","article-title":"Anti-Axl antibody treatment reduces the severity of experimental autoimmune encephalomyelitis","volume":"17","author":"DuBois","year":"2020","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1124\/jpet.124.002254_bib13","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/nature17630","article-title":"TAM receptors regulate multiple features of microglial physiology","volume":"532","author":"Fourg\u00e9aud","year":"2016","journal-title":"Nature"},{"key":"10.1124\/jpet.124.002254_bib14","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.3390\/molecules26133943","article-title":"CD47 in the brain and neurodegeneration: an update on the role in neuroinflammatory pathways","volume":"26","author":"Gheibihayat","year":"2021","journal-title":"Molecules"},{"key":"10.1124\/jpet.124.002254_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2008.08.076","article-title":"Axl-\/- mice have delayed recovery and prolonged axonal damage following cuprizone toxicity","volume":"1240","author":"Hoehn","year":"2008","journal-title":"Brain Res"},{"key":"10.1124\/jpet.124.002254_bib16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.tins.2023.11.005","article-title":"Toward identifying key mechanisms of progression in multiple sclerosis","volume":"47","author":"Husseini","year":"2024","journal-title":"Trends Neurosci"},{"key":"10.1124\/jpet.124.002254_bib17","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1016\/j.cell.2022.08.021","article-title":"Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course","volume":"185","year":"2022","journal-title":"Cell"},{"key":"10.1124\/jpet.124.002254_bib18","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41590-024-01765-5","article-title":"A\u00a0repair pathway lost in multiple sclerosis provides a new drug opportunity","volume":"25","author":"Jensen","year":"2024","journal-title":"Nat Immunol"},{"key":"10.1124\/jpet.124.002254_bib19","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/s41593-022-01097-3","article-title":"Identification of early neurodegenerative pathways in progressive multiple sclerosis","volume":"25","author":"Kaufmann","year":"2022","journal-title":"Nat Neurosci"},{"key":"10.1124\/jpet.124.002254_bib20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41582-023-00801-6","article-title":"Inflammation in multiple sclerosis: consequences for remyelination and disease progression","volume":"19","author":"Klotz","year":"2023","journal-title":"Nat Rev Neurol"},{"key":"10.1124\/jpet.124.002254_bib21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","article-title":"Multiple sclerosis progression: time for a new mechanism-driven framework","volume":"22","author":"Kuhlmann","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1124\/jpet.124.002254_bib22","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41590-024-01756-6","article-title":"The astrocyte-produced growth factor HB-EGF limits autoimmune CNS pathology","volume":"25","author":"Linnerbauer","year":"2024","journal-title":"Nat Immunol"},{"key":"10.1124\/jpet.124.002254_bib23","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1002\/glia.23480","article-title":"Glio- and neuro-protection by prosaposin is mediated by orphan G-protein coupled receptors GPR37L1 and GPR37","volume":"66","author":"Liu","year":"2018","journal-title":"Glia"},{"key":"10.1124\/jpet.124.002254_bib24","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.46.4.907","article-title":"Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis","volume":"46","author":"Lublin","year":"1996","journal-title":"Neurology"},{"key":"10.1124\/jpet.124.002254_bib25","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: the 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"key":"10.1124\/jpet.124.002254_bib26","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.immuni.2018.10.016","article-title":"Modulation of host immunity by helminths: the expanding repertoire of parasite effector molecules","volume":"49","author":"Maizels","year":"2018","journal-title":"Immunity"},{"key":"10.1124\/jpet.124.002254_bib27","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining trained immunity and its role in health and disease","volume":"20","author":"Netea","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1124\/jpet.124.002254_bib28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12974-023-02921-8","article-title":"Mertk-expressing microglia influence oligodendrogenesis and myelin modelling in the CNS","volume":"20","author":"Nguyen","year":"2023","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1124\/jpet.124.002254_bib29","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jpha.2023.06.011","article-title":"Integrative multi-omics and systems bioinformatics in translational neuroscience: a data mining perspective","volume":"13","author":"O\u2019Connor","year":"2023","journal-title":"J\u00a0Pharm Anal"},{"key":"10.1124\/jpet.124.002254_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009176","article-title":"GAS6 signaling tempers Th17 development in patients with multiple sclerosis and helminth infection","volume":"16","author":"Ortiz Wilczy\u00f1ski","year":"2020","journal-title":"PLoS Pathog"},{"key":"10.1124\/jpet.124.002254_bib31","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3390\/cells10040884","article-title":"FGF\/FGFR pathways in multiple sclerosis and in its disease models","volume":"10","author":"Rajendran","year":"2021","journal-title":"Cells"},{"key":"10.1124\/jpet.124.002254_bib32","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev-immunol-032414-112103","article-title":"TAM receptor signaling in immune homeostasis","volume":"33","author":"Rothlin","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"10.1124\/jpet.124.002254_bib33","doi-asserted-by":"crossref","first-page":"e2107","DOI":"10.1212\/WNL.0000000000005685","article-title":"The cortical damage, early relapses, and onset of the progressive phase in multiple sclerosis","volume":"90","author":"Scalfari","year":"2018","journal-title":"Neurology"},{"key":"10.1124\/jpet.124.002254_bib34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pharmthera.2018.03.002","article-title":"The role of TAM family receptors and ligands in the nervous system: from development to pathobiology","volume":"188","author":"Shafit-Zagardo","year":"2018","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.124.002254_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108835","article-title":"Multiple sclerosis risk gene Mertk is required for microglial activation and subsequent remyelination","volume":"34","author":"Shen","year":"2021","journal-title":"Cell Rep"},{"key":"10.1124\/jpet.124.002254_bib36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41579-022-00770-5","article-title":"Epstein-Barr virus and multiple sclerosis","volume":"21","author":"Soldan","year":"2022","journal-title":"Nat Rev Microbiol"},{"key":"10.1124\/jpet.124.002254_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015748","article-title":"GAS6 enhances repair following cuprizone-induced demyelination","volume":"5","author":"Tsiperson","year":"2010","journal-title":"PLoS One"},{"key":"10.1124\/jpet.124.002254_bib38","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1742-2094-8-49","article-title":"Loss of the receptor tyrosine kinase\u00a0Axl leads to enhanced inflammation in the CNS and delayed removal of myelin\u00a0debris during experimental autoimmune encephalomyelitis","volume":"8","author":"Weinger","year":"2011","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1124\/jpet.124.002254_bib39","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a029009","article-title":"Regulation of astrocyte functions in multiple sclerosis","volume":"9","author":"Wheeler","year":"2019","journal-title":"Cold Spring Harb Perspect Med"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524000879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524000879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.124.002254","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T18:10:55Z","timestamp":1738260655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524000879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0022356524000879"],"URL":"https:\/\/doi.org\/10.1124\/jpet.124.002254","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New potential ligand-receptor axis involved in tissue repair as therapeutic targets in progressive multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.124.002254","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100029"}}